Capital Management Inc. Occitan, 10% Owner at Alexza Pharmaceuticals Inc. (ALXA), bought 98,941 shares at $0.80 ($81K) on 2012-01-13, disclosed to the SEC on 2012-01-20.
Open-market purchase of $81k ALXA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.92 | 100 | $92 | 0.1% |
| 2 | $0.92 | 500 | $460 | 0.6% |
| 3 | $0.92 | 700 | $644 | 0.8% |
| 4 | $0.92 | 2,500 | $2K | 2.8% |
| 5 | $0.84 | 1,000 | $840 | 1.0% |
| 6 | $0.84 | 2,441 |
| $2K |
| 2.5% |
| 7 | $0.84 | 5,000 | $4K | 5.2% |
| 8 | $0.87 | 5,000 | $4K | 5.4% |
| 9 | $0.87 | 10,000 | $9K | 10.7% |
| 10 | $0.80 | 1,900 | $2K | 1.9% |
| 11 | $0.80 | 9,800 | $8K | 9.6% |
| 12 | $0.80 | 10,000 | $8K | 9.8% |
| 13 | $0.80 | 15,000 | $12K | 14.8% |
| 14 | $0.80 | 25,000 | $20K | 24.6% |
| 15 | $0.83 | 10,000 | $8K | 10.2% |
| Total | $0.82 avg | 98,941 | $81K | 100% |